miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension

References

• ThenappanTOrmistonMLRyanJJArcherSLPulmonary arterial hypertension: pathogenesis and clinical managementBMJ2018360j549229540357
   PubMed Web of Science ®Google Scholar
• ChenDGaoWWangSNiBGaoYCritical effects of epigenetic regulation in pulmonary arterial hypertensionCell Mol Life Sci201774203789380828573430
   PubMed Web of Science ®Google Scholar
• SakaoSVoelkelNFTatsumiKThe vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterationsEur Respir Rev20142313335035525176971
   PubMedGoogle Scholar
• WrobelJPThompsonBRWilliamsTJMechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic reviewJ Heart Lung Transplant201231655756422502811
   PubMed Web of Science ®Google Scholar
• NikitopoulouIOrfanosSEKotanidouAVascular endothelial-cadherin downregulation as a feature of endothelial transdifferentiation in monocrotaline-induced pulmonary hypertensionAm J Physiol Lung Cell Mol Physiol20163112L352L36327233997
   PubMed Web of Science ®Google Scholar
• OgoshiTTsutsuiMKidoTProtective Role of Myelocytic Nitric Oxide Synthases against Hypoxic Pulmonary Hypertension in MiceAm J Respir Crit Care Med2018198223224429480750
   PubMed Web of Science ®Google Scholar
• LimHKLimHKRyooSMitochondrial arginase II constrains endothelial NOS-3 activityAm J Physiol Heart Circ Physiol20072936H3317H332417827260
   PubMed Web of Science ®Google Scholar
• KrauseBJCarrasco-WongICaniuguirACarvajalJFaríasMCasanelloPEndothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vesselsPlacenta2013341202823122700
   PubMed Web of Science ®Google Scholar
• SwamynathanSKKrüppel-like factors: three fingers in controlHum Genomics20104426327020511139
   PubMedGoogle Scholar
• MorrisVACummingsCLKorbBBoaglioSOehlerVGDeregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene TargetsMol Cell Biol201636455957326644403
   PubMed Web of Science ®Google Scholar
• LuYZhangLLiaoXKruppel-like factor 15 is critical for vascular inflammationJ Clin Invest2013123104232424123999430
   PubMed Web of Science ®Google Scholar
• PatelSKRamchandJCrocittiVBurrellLMKruppel-Like Factor 15 Is Critical for the Development of Left Ventricular HypertrophyInt J Mol Sci20181951303
   Web of Science ®Google Scholar
• PandeyDNomuraYRossbergMCHypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary EndotheliumArterioscler Thromb Vasc Biol201838491392629472234
   PubMed Web of Science ®Google Scholar
• KaiserRFrantzCBalsRWilkensHThe role of circulating throm-bospondin-1 in patients with precapillary pulmonary hypertensionRespir Res20161719627473366
   PubMed Web of Science ®Google Scholar
• HamamRHamamDAlsalehKACirculating microRNAs in breast cancer: novel diagnostic and prognostic biomarkersCell Death Dis201789e304528880270
   PubMed Web of Science ®Google Scholar
• JakobPKacprowskiTBriand-SchumacherSProfiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarctionEur Heart J201738751151528011706
   PubMed Web of Science ®Google Scholar
• BaptistaRMarquesCCatarinoSMicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1Cardiovasc Res20181141536429016730
   PubMed Web of Science ®Google Scholar
• ChenWLiSCirculating microRNA as a novel biomarker for pulmonary arterial hypertension due to congenital heart diseasePediatr Cardiol2017381869427837306
   PubMed Web of Science ®Google Scholar
• JinPGuWLaiYZhengWZhouQWuXThe Circulating MicroRNA-206 level predicts the severity of pulmonary hypertension in patients with left heart diseasesCell Physiol Biochem20174162150216028554172
   PubMedGoogle Scholar
• NallamshettySChanSYLoscalzoJHypoxia: a master regulator of microRNA biogenesis and activityFree Radic Biol Med201364203023712003
   PubMed Web of Science ®Google Scholar
• GrecoSMartelliFMicroRNAs in Hypoxia ResponseAntioxid Redox Signal20142181164116625098394
   PubMed Web of Science ®Google Scholar
• LiuHYinTYanWDysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertensionInt J Chron Obstruct Pulmon Dis2017121781179128684904
   PubMed Web of Science ®Google Scholar
• LiuHTaoYChenMUpregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2Sci Rep201662466127381447
   PubMed Web of Science ®Google Scholar
• HaleAEWhiteKChanSYHypoxamirs in pulmonary hypertension: breathing new life into pulmonary vascular researchCardiovasc Diagn Ther20122320021223745175
   PubMedGoogle Scholar
• LiSSRanYJZhangDDLiSZZhuDMicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K+ channel in arterial smooth muscle cellsJ Cell Biochem201411561196120524446351
   PubMed Web of Science ®Google Scholar
• BlissenbachBNakasCTKrönkeMGeiserTMerzTMPichler HeftiJHypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitudeAm J Physiol Lung Cell Mol Physiol20183141L157L16428971974
   PubMed Web of Science ®Google Scholar
• BrownLMChenHHalpernSDelay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryChest20111401192621393391
   PubMed Web of Science ®Google Scholar
• GalièNHumbertMVachieryJL2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)Eur Respir J201546490397526318161
   PubMed Web of Science ®Google Scholar
• WangLJinYZZhaoQHHemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertensionInt J Chron Obstruct Pulmon Dis2017123353336029200842
   PubMed Web of Science ®Google Scholar
• SeegerWAdirYBarberàJAPulmonary hypertension in chronic lung diseasesJ Am Coll Cardiol20136225 SupplD109D11624355635
   PubMed Web of Science ®Google Scholar
• LaoBBGrishaginIMesallatiHBrewerTFOlenyukBZAroraPSIn vivo modulation of hypoxia-inducible signaling by topographical helix mimeticsProc Natl Acad Sci U S A2014111217531753624821806
   PubMed Web of Science ®Google Scholar
• KubliDAZhangXLeeYParkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarctionJ Biol Chem2013288291592623152496
   PubMed Web of Science ®Google Scholar
• PullamsettiSSDoebeleCFischerAInhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertensionAm J Respir Crit Care Med2012185440941922161164
   PubMed Web of Science ®Google Scholar
• BrockMSamillanVJTrenkmannMAntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertensionEur Heart J201435453203321122450430
   PubMed Web of Science ®Google Scholar
• Samareh FekriMTorabiMAzizi ShoulSMirzaeeMPrevalence and predictors associated with severe pulmonary hypertension in COPDAm J Emerg Med201836227728028797558
   PubMed Web of Science ®Google Scholar
• PortilloKTorralbaYBlancoIPulmonary hemodynamic profile in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101313132026203238
   PubMed Web of Science ®Google Scholar
• TakemotoMSunJHirokiJShimokawaHLiaoJKRho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthaseCirculation20021061576212093770
   PubMed Web of Science ®Google Scholar
• KoudelkaAAmbrozovaGKlinkeANitro-Oleic Acid Prevents Hypoxia- and Asymmetric Dimethylarginine-Induced Pulmonary Endothelial DysfunctionCardiovasc Drugs Ther201630657958627858190
   PubMed Web of Science ®Google Scholar
• DulucLAhmetaj-ShalaBMitchellJTipifarnib prevents development of hypoxia-induced pulmonary hypertensionCardiovasc Res2017113327628728395021
   PubMed Web of Science ®Google Scholar
• DuboisMDelannoyEDulucLBiopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in micePLoS One2013811e8259424312428
   PubMed Web of Science ®Google Scholar
• KimSYLeeJHHuhJWBortezomib alleviates experimental pulmonary arterial hypertensionAm J Respir Cell Mol Biol201247569870822842494
   PubMed Web of Science ®Google Scholar
• ZhangRWangXJZhangHDProfiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertensionEur Respir J20164851386139527660508
   PubMed Web of Science ®Google Scholar
• HajianBde BackerJVosWPulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertensionInt J Chron Obstruct Pulmon Dis2016111533154127462149
   PubMed Web of Science ®Google Scholar
• PandeyDBhuniaAOhYJOxLDL triggers retrograde translocation of arginase2 in aortic endothelial cells via ROCK and mitochondrial processing peptidaseCirc Res2014115445045924903103
   PubMed Web of Science ®Google Scholar
• SikkaGPandeyDBhuniyaAKContribution of arginase activation to vascular dysfunction in cigarette smokingAtherosclerosis20132311919424125417
   PubMed Web of Science ®Google Scholar
• KeymelSSchuellerBSansoneROxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary diseaseArch Med Sci201814229730629593802
   PubMed Web of Science ®Google Scholar
• ShaoNYHuHYYanZComprehensive survey of human brain microRNA by deep sequencingBMC Genomics20101140920591156
   PubMed Web of Science ®Google Scholar